Weily Soong

Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial

Diamant Thaçi, Eric L. Simpson, Lisa A. Beck et al. · The Lancet · 2015 · 560 citations

Allergy, Atopic Dermatitis, Allergy Medicine +7

Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial

Kristian Reich, Henrique D. Teixeira, Marjolein de Bruin‐Weller et al. · The Lancet · 2021 · 366 citations

Atopic Dermatitis, Medicine, Moderate-to-severe Atopic Dermatitis +9

Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial

Steven G. Kelsen, Ioana Agache, Weily Soong et al. · Journal of Allergy and Clinical Immunology · 2021 · 285 citations

Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study

Mette Deleuran, Diamant Thaçi, Lisa A. Beck et al. · Journal of the American Academy of Dermatology · 2019 · 248 citations · Full text

Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial

Amy S. Paller, Eric L. Simpson, Elaine C. Siegfried et al. · The Lancet · 2022 · 242 citations · Full text

Asthma, Uncontrolled Atopic Dermatitis, Atopic Dermatitis +4